LAWRENCE, Mass., Sept. 10,
2014 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a
leading manufacturer of innovative dialysis products, is proud to
support four kidney failure patients performing home hemodialysis
(HHD) treatment with the NxStage® System One™ as they ride in the
eighth annual Tour DaVita®. Beginning on September 14 in Oregon, each patient will bike up to 257 miles
over the course of three days, raising awareness for kidney disease
and dialysis treatment options, including HHD. Thanks to the
portability and flexibility of treatment schedules with the NxStage
System One, all four patients will dialyze in a recreational
vehicle along the route with the support of a care partner.
"Riding in Tour DaVita 2012 and 2013 gave me the confidence to
lead an active lifestyle while on dialysis," said Alphonso Jefferson, current NxStage patient and
one of the first-ever HHD Tour DaVita patient riders. "It's
incredible that other HHD patients want to participate in something
amazing like this ride; none of which would be possible without the
System One's portability and flexible treatment schedule."
Jefferson's trailblazing efforts as an active member of previous
Tour DaVita rides have paved the way for at least four other
NxStage System One patients, including Thomas Holmes (third tour), Jan Morrow (second tour), Jacqueline Harris, and Lisa Rodriguez-Linner, to participate in the
2014 ride.
"Supporting our patients and their impressive accomplishments is
at the heart of everything we do at NxStage," said Joe Turk, president of NxStage Medical. "It's
incredibly inspiring that because of our portable technology HHD
patients are able to travel to and participate in this great event.
We are proud to be part of their efforts to raise awareness for
kidney disease and the proven clinical and lifestyle benefits of
home hemodialysis."
Tour DaVita, which receives support from NxStage, is an annual
ride that raises awareness of kidney disease and funds for medical
missions both in the United States
and abroad. All funds are donated to DaVita Village Trust, an
organization that aspires to improve community health, wellness and
vitality, including chronic kidney disease education, prevention
and treatment. Last year's fundraising efforts raised more than
$1 million. For more information on
Tour DaVita 2014 please visit www.tourdavita.org.
Tour DaVita is a registered trademark of DaVita Healthcare
Partners Inc.
Despite the health benefits that home hemodialysis may
provide to those with chronic kidney disease, this form of therapy
is not for everyone. The reported benefits of home hemodialysis may
not be experienced by all patients. The risks associated with
hemodialysis treatments in any environment include, but are not
limited to, high blood pressure, fluid overload, low blood
pressure, heart-related issues, and vascular access complications.
The medical devices used in hemodialysis therapies may add
additional risks including air entering the bloodstream and blood
loss due to clotting or accidental disconnection of the blood
tubing set. Certain risks are unique to the home. Treatments at
home are done without the presence of medical personnel and on-site
technical support. Patients and their partners must be trained on
what to do and how to get medical or technical help if
needed.
About the NxStage System One
The NxStage System
One is the first and only truly portable hemodialysis system
cleared for home use by the U.S. Food & Drug
Administration (FDA). Its simplicity and revolutionary size
(just over a foot tall) are intended to allow convenient use in
patients' homes and give patients the freedom to travel with their
therapy. When combined with the NxStage PureFlow SL Dialysis
Preparation System, patients are able to further simplify, using
ordinary tap water to create dialysis fluid. Unlike conventional
hemodialysis systems, the System One requires no special
infrastructure to operate. Under the guidance of their physician,
patients can use the NxStage System One, with their trained
partners, where, how and when it best meets their needs - at home
or on vacation and at a medically appropriate treatment
frequency. http://www.nxstage.com/.
About NxStage Medical,
Inc.
NxStage is a medical device company,
headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
ESRD and acute kidney failure. For more information on NxStage and
its products, please visit the Company's website
at www.nxstage.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and
Exchange Commission, including the Quarterly Report on Form 10-Q
for the quarter ended June 30, 2014. NxStage is under no
obligation to (and expressly disclaims any such obligation to)
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
Media contact:
Kristen K. Sheppard, Esq.
VP of Investor Relations
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
SOURCE NxStage Medical Inc.